IL18 and breast cancer: LGR-1 attenuated BC-induced NLRP3 inflammasome activity and significantly reduced NLRP3 inflammasome activity and expressions of IL-1β and IL-18 caused by LPS + ATP (Fig. 5A–F, P < 0.05).